Nuclei isolation and 1 more item

NOVOGENE CORPORATION INC has been awarded contract A207_PO-0474066 by the University of Virginia, an entity within the Commonwealth of Virginia. The contract was executed on August 27, 2026, with a cumulative contract value of $11,394.00. While the specific products and services to be delivered under this purchase order are not detailed in the available contract documentation, the nature of the work can be reasonably inferred from the contractor's core business operations in genomic sequencing and related bioinformatics services, which are commonly procured by academic research institutions.

The University of Virginia, serving as the contracting organization, represents the performance location for this engagement. The contract represents a relatively modest procurement transaction, suggesting either a limited-scope project or a unit purchase order within a broader blanket agreement. Complete details regarding the period of performance, specific deliverables, and technical specifications are not contained within the provided award documentation and would require review of the underlying purchase order and statement of work for comprehensive contract analysis.